Northern Trust Corp Enanta Pharmaceuticals Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 536,705 shares of ENTA stock, worth $5.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
536,705
Previous 845,116 36.49%
Holding current value
$5.01 Million
Previous $11 Million 49.23%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$10.05 - $16.54 $3.1 Million - $5.1 Million
-308,411 Reduced 36.49%
536,705 $5.57 Million
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $1.01 Million - $1.5 Million
-88,240 Reduced 9.45%
845,116 $11 Million
Q1 2024

May 14, 2024
SELL
$10.08 - $17.46 $21,540 - $37,312
-2,137 Reduced 0.23%
933,356 $16.3 Million
Q4 2023

Feb 13, 2024
SELL
$8.18 - $10.78 $199,698 - $263,172
-24,413 Reduced 2.54%
935,493 $8.8 Million
Q3 2023

Nov 13, 2023
SELL
$11.09 - $22.13 $164,919 - $329,095
-14,871 Reduced 1.53%
959,906 $10.7 Million
Q2 2023

Aug 11, 2023
BUY
$20.68 - $39.85 $2.31 Million - $4.44 Million
111,461 Added 12.91%
974,777 $20.9 Million
Q1 2023

May 15, 2023
SELL
$38.82 - $54.59 $769,179 - $1.08 Million
-19,814 Reduced 2.24%
863,316 $34.9 Million
Q4 2022

Feb 13, 2023
SELL
$40.77 - $53.73 $3.31 Million - $4.37 Million
-81,277 Reduced 8.43%
883,130 $41.1 Million
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $1.6 Million - $2.36 Million
33,116 Added 3.56%
964,407 $50 Million
Q2 2022

Aug 12, 2022
BUY
$38.13 - $76.93 $121,939 - $246,022
3,198 Added 0.34%
931,291 $44 Million
Q1 2022

May 13, 2022
SELL
$56.06 - $74.11 $4.71 Million - $6.23 Million
-84,071 Reduced 8.31%
928,093 $66.1 Million
Q4 2021

Feb 08, 2022
BUY
$60.19 - $97.37 $3.2 Million - $5.17 Million
53,116 Added 5.54%
1,012,164 $75.7 Million
Q3 2021

Nov 15, 2021
BUY
$41.02 - $58.65 $12.7 Million - $18.2 Million
310,246 Added 47.82%
959,048 $54.5 Million
Q2 2021

Aug 13, 2021
BUY
$43.76 - $53.11 $170,138 - $206,491
3,888 Added 0.6%
648,802 $28.6 Million
Q1 2021

May 12, 2021
BUY
$41.69 - $54.95 $17 Million - $22.4 Million
407,185 Added 171.28%
644,914 $31.8 Million
Q4 2020

Feb 11, 2021
SELL
$41.16 - $47.47 $424,441 - $489,510
-10,312 Reduced 4.16%
237,729 $10 Million
Q3 2020

Nov 16, 2020
SELL
$43.36 - $53.53 $286,999 - $354,315
-6,619 Reduced 2.6%
248,041 $11.4 Million
Q2 2020

Aug 14, 2020
SELL
$46.37 - $57.58 $181,121 - $224,907
-3,906 Reduced 1.51%
254,660 $12.8 Million
Q1 2020

May 14, 2020
BUY
$40.22 - $62.0 $976,058 - $1.5 Million
24,268 Added 10.36%
258,566 $13.3 Million
Q4 2019

Feb 14, 2020
SELL
$57.95 - $66.61 $425,874 - $489,516
-7,349 Reduced 3.04%
234,298 $14.5 Million
Q3 2019

Nov 13, 2019
BUY
$60.08 - $88.17 $457,208 - $670,973
7,610 Added 3.25%
241,647 $14.5 Million
Q2 2019

Aug 13, 2019
BUY
$81.3 - $97.35 $216,014 - $258,658
2,657 Added 1.15%
234,037 $19.7 Million
Q1 2019

May 13, 2019
SELL
$69.08 - $105.66 $650,940 - $995,634
-9,423 Reduced 3.91%
231,380 $22.1 Million
Q4 2018

Feb 12, 2019
BUY
$65.41 - $84.65 $602,229 - $779,372
9,207 Added 3.98%
240,803 $17.1 Million
Q3 2018

Nov 14, 2018
BUY
$85.46 - $126.37 $654,025 - $967,109
7,653 Added 3.42%
231,596 $19.8 Million
Q2 2018

Sep 18, 2018
SELL
$81.85 - $120.51 $99,202 - $146,058
-1,212 Reduced 0.54%
223,943 $26 Million
Q2 2018

Aug 14, 2018
BUY
$81.85 - $120.51 $2.73 Million - $4.02 Million
33,325 Added 17.37%
225,155 $26.1 Million
Q1 2018

May 09, 2018
SELL
$57.91 - $92.15 $493,798 - $785,763
-8,527 Reduced 4.26%
191,830 $15.5 Million
Q4 2017

Feb 14, 2018
BUY
$45.65 - $59.37 $220,672 - $286,994
4,834 Added 2.47%
200,357 $11.8 Million
Q3 2017

Nov 13, 2017
BUY
$37.91 - $46.8 $7.41 Million - $9.15 Million
195,523
195,523 $9.15 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email